Martin Guppy shares his views on what the future of drug discovery may look like
San Francisco seeking to be the world’s top biotech cluster
Cambridge in the greater Boston area calls itself the most innovative square mile on the planet but San Francisco’s Bay Area is snapping at it heels
Why US biotechs increasingly choose Switzerland for their European HQ
Why a combination of talent, tax, environment and infrastructure makes Switzerland a particularly attractive option for US biotechs.
Understanding Generation Z
Generation Z (born between 1995-2010) is attracting much discussion about what its attitudes to social issues, gender politics and the workplace mean for corporations, brands and other institutions. In this article we explore how this generation’s experiences and expectations are likely to shape the future of healthcare.